Cystic Fibrosis Drug Wins Approval of F.D.A. Advisory Panel (New York Times)
A federal advisory committee on Tuesday recommended approval of Orkambi, a drug from Vertex Pharmaceuticals that might eventually help nearly half of patients with cystic fibrosis.
Seasonal Genes (The Scientist)
Our immune systems vary with the seasons, according to a study that could help explain why certain conditions such as heart disease and rheumatoid arthritis are aggravated in winter while people tend to be healthier in the summer.
Common vitamin reduces recurrence of some skin cancers (The Washington Post)
Nicotinamide, a cheap over-the-counter vitamin, appears to reduce recurrence of some common skin cancers associated with sun exposure for people who have had them before, researchers at the University of Sydney report.
Wearable MD: How Fitness Trackers Can Change Healthcare (PC Mag.com)
Popular computing’s take on activity trackers and other wearable fitness devices.
Concussions Can Be More Likely In Practices Than In Games (NPR)
Parents worry about a child getting a concussion in the heat of competition, but they also need to be thinking about what happens during practices, a study finds.
A 2-Minute Walk May Counter the Harms of Sitting (NYTimes Blog)
A new study suggests that even a few minutes per hour of moving instead of remaining in a chair might substantially reduce the harms of oversitting.